Inflammation and Heart Failure: Searching for the Enemy-Reaching the Entelechy.

J Cardiovasc Dev Dis · 2023 · PMC9866611 · PMID 36661914

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

On the other hand, the CANTOS trial has shown that the inhibition of IL-1b with canakinumab was followed by a significant trend for a dose-dependent reduction in the incidence of the composite endpoint of hospitalization for heart failure and heart failure-related mortality [ 75 ].

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.